Table 1 General characteristics of all patients

Age (years), median (IQR)

72 (62, 78.25)

Sex, M/F (%)

131/79 (62.4/37.6)

Dialysis vintage (months), median (IQR)

34 (20.75, 66)

Nephropathy

-Diabetic

-Nephrosclerosis

-Glomerulonephritis

-Autosomal dominant polycystic kidney disease (ADPKD)

-Unknown etiology

-Chronic tubulointerstitial nephritis

89 (42.4)

35 (16.7)

26 (12.4)

15 (7.1)

32 (15.2)

13 (6.2)

Diabetes, n(%)

99 (47.1)

Hypertension, n(%)

201 (95.7)

Smoking status, n(%)

80 (38.1)

CAD, n(%)

82 (39)

Cancer, n(%)

28 (13.3)

Hepatitis B, n(%)

0 (0)

Hepatitis C, n(%)

0 (0)

Hemoglobin over one year, median (IQR)

Hemoglobin ≥ 11 g/dL, n(%)

Hemoglobin ≥ 10.5 g/dL, n(%)

11.27 (10.78, 11.78)

132 (62.9)

176 (83.8)

Ferritin over one year, ng/mL, mean ± SD

533.89 ± 258.26

TSAT over one year, median (IQR)

TSAT ≥ 20%, n(%)

0.26 (0.21, 0.31)

172 (81.9)

Serum calcium over one year, mg/dL, mean ± SD

9.01 ± 0.48

Serum phosphate over one year, mg/dL, mean ± SD

Serum phosphate < 5 mg/dL, n(%)

4.4 ± 1.1

175 (83.3)

PTH, over one year, pg/mL, median (IQR)

232.4 (129.7, 413.2)

URR over one year, mean ± SD

0.75 ± 0.05

Serum potassium over one year, median (IQR)

Serum potassium > 6meq/L, n(%)

5.11 (4.73, 5.45)

13 (6.2)

RAAS inhibitors intake, n(%)

23 (11)

Monthly dose of ESA over one year, UI, median (IQR)

21833.5 (14958.25, 40833.0)

Monthly dose of IV Iron ampoules (100 mg) over one year, mean ± SD

1.15 ± 1.07

Weekly dose of alfacalcidol, µg, median (IQR)

1 (0, 2)

Calcium-based phosphate binder (CBB), n(%)

172 (81.9)

Non-calcium-based phosphate binder (NCBB), n(%)

94 (44.8)

Yearly number of interventions in ESA prescription, mean ± SD

Median (IQR)

4.63 ± 2.62

5 (3, 7)

Yearly number of interventions in IV iron prescription, mean ± SD

Median (IQR)

4.25 ± 0.1

4 (2, 6)

Yearly number of interventions in alfacalcidol prescription, median (IQR)

0 (0, 1)

Yearly number of interventions in CBB prescription, median (IQR)

0 (0, 2)

Yearly number of interventions in NCBB prescription, median (IQR)

0 (0, 1)

Yearly number of interventions in any phosphate binder prescription, median (IQR)

1 (0, 2.25)

Yearly number of interventions in cinacalcet prescription, median (IQR)

0 (0, 0)

Yearly number of interventions in kayexalate prescription, median (IQR)

0 (0, 0)

Yearly number of interventions in potassium dialysate prescription, median (IQR)

0 (0, 1)

Yearly number of interventions in session duration prescription, median (IQR)

0 (0, 0)

Yearly number of interventions in filter surface prescription, median (IQR)

0 (0, 0)